Acurx Pharmaceuticals LLC (ACXP)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | HARRISON, THOMAS L | Director | Stock Option | Acquisition | 2,150 | 0 |
| Apr 20, 2026 | SAILER, CARL | Director | Stock Option | Acquisition | 2,150 | 0 |
| Apr 20, 2026 | SHAWAH, ROBERT G. | Chief Financial Officer | Stock Option | Acquisition | 25,900 | 0 |
| Apr 20, 2026 | LUCI, DAVID P | Director, President and CEO | Stock Option | Acquisition | 37,100 | 0 |
| Apr 20, 2026 | DELUCCIA, ROBERT J | Director | Stock Option | Acquisition | 37,100 | 0 |
| Apr 20, 2026 | SCODARI, JOSEPH C | Director | Stock Option | Acquisition | 2,150 | 0 |
| Apr 20, 2026 | DEAN, JACK H | Director | Stock Option | Acquisition | 2,150 | 0 |
| Apr 20, 2026 | DONOHUE, JAMES J. | Director | Stock Option | Acquisition | 2,150 | 0 |